It has also been reported that IL‐5Rα expression is functionally reduced in lung tissue compared to circulating eosinophils,12 which may explain the mechanism by which EGPA develops during benralizumab administration. Here, IL5RA is linked to eosinophilic granulomatosis with polyangiitis.